According to IMARC Group, the global Atherectomy Devices Market size reached USD 1,066.4 Million in 2025 and is projected to reach USD 1,553.7 Million by 2034, growing at a CAGR of 4.14% during 2026–2034. This steady growth reflects the rising burden of cardiovascular disease, expanding healthcare infrastructure, and rapid advancements in device technology across both developed and emerging economies.
Atherectomy Devices Market Size Industry Overview
The Atherectomy Devices Market Size and overall industry overview reveals a market driven by the intersection of clinical need and technological progress. Atherectomy refers to a minimally invasive surgical procedure that removes plaque from arterial walls to restore normal blood flow. Unlike balloon angioplasty or stenting, atherectomy physically excises or ablates the plaque, offering a distinctive clinical advantage in complex lesion management.
Key atherectomy procedures and device categories include:
- Directional Atherectomy – Targeted plaque excision with precision control
- Orbital Atherectomy – Sanding down calcified plaque using an orbital motion
- Rotational Atherectomy – High-speed burr grinding for heavily calcified lesions
- Photo-Ablative (Laser) Atherectomy – Laser energy to vaporize plaque
- Support Devices – Ancillary tools for procedural guidance and access
These technologies are deployed across peripheral vascular, cardiovascular, and neurovascular applications, serving hospitals, ambulatory surgery centers, and research institutions globally.
Global Atherectomy Devices Market Share Key Statistics
Below are the key Atherectomy Devices Market Share statistics drawn from IMARC Group's comprehensive market analysis:
Base Year - 2025
Historical Period - 2020–2025
Forecast Period - 2026–2034
Market Size in 2025 - USD 1,066.4 Million
Market Forecast in 2034 - USD 1,553.7 Million
Market Growth Rate (2026–2034) - 4.14% CAGR
Largest Region - North America
Largest Product Segment - Directional Atherectomy Devices
Largest Application Segment - Peripheral Vascular
Largest End User Segment - Hospitals
Request for a Sample Report for Detailed Market Insights Evaluation: https://www.imarcgroup.com/atherectomy-devices-market/requestsample
Key Atherectomy Devices Market Trends Drivers in 2025
Several powerful forces are shaping the Atherectomy Devices Market Trends and fueling sustained growth across global healthcare markets:
- Rising Cases of Peripheral Artery Disease (PAD)
The increasing global prevalence of PAD, driven by aging populations and growing rates of diabetes and obesity, is the primary engine of atherectomy device demand. PAD affects approximately 8 to 12 million people in the United States alone, particularly those over 50. Atherectomy devices provide a minimally invasive approach to remove arterial plaque, restoring blood flow, relieving symptoms such as leg pain and fatigue, and significantly improving outcomes for patients with severe PAD.
- Technological Advancements in Device Design
Continuous innovation is transforming the atherectomy devices landscape. Modern directional atherectomy systems now offer enhanced precision control, reducing vessel wall trauma during plaque removal. Studies indicate that orbital atherectomy opens blocked leg arteries effectively approximately 90% of the time, while laser atherectomy achieves improved blood flow in 76% of cases. Jetstream atherectomy demonstrated 99% device success in a multicenter study of 172 patients, with strong 12-month clinical outcomes.
- Growing Preference for Minimally Invasive Surgeries
Both patients and surgeons increasingly favor minimally invasive procedures over open surgery due to reduced risks of infection, minimal pain and trauma, shorter hospital stays, and faster recovery. Atherectomy's minimally invasive profile positions it as a preferred alternative for complex arterial interventions, directly driving device adoption across all clinical settings.
- Expansion of Healthcare Infrastructure in Emerging Markets
Prominent market players are targeting emerging economies where healthcare infrastructure investment and spending are accelerating. BRICS nations — Brazil, Russia, India, China, and South Africa — are increasingly shaping global demand for advanced medical devices. Projected healthcare spending as a percentage of GDP by 2030 underscores this growth: Brazil (8.4%), South Africa (10.4%), China (5.9%), Russia (5.2%), and India (3.5%). As these markets adopt more advanced cardiovascular treatment alternatives, the global footprint of atherectomy devices continues to expand.
- Rising Aging Population
Cardiovascular diseases disproportionately affect older populations. The global demographic shift toward an aging population is therefore directly increasing the patient pool for atherectomy procedures. As life expectancy rises worldwide, the need for effective, low-risk vascular interventions is poised to grow substantially through the forecast period.
- Favorable Reimbursement Policies
In developed markets, particularly the United States, supportive reimbursement scenarios for atherectomy procedures encourage both provider adoption and patient access. Government support for RD in advanced medical devices further accelerates innovation and clinical uptake. In emerging economies, improving reimbursement situations are expanding device availability and usage.
Atherectomy Devices Market Analysis: Key Segmentation
A comprehensive Atherectomy Devices Market Analysis reveals distinct patterns across product type, application, and end-user segments:
By Product
Directional Atherectomy Devices — Largest Segment
Directional atherectomy devices command the largest product segment share due to their precise plaque excision capabilities and reduced vessel wall trauma. These instruments allow accurate control, which is a critical factor for patient safety and recovery. Their ability to treat complex lesions across multiple vessel sizes makes them the preferred choice of vascular specialists. The capability to collect and physically remove plaque during the procedure — rather than compress it — sets these devices apart and makes them advantageous across a broad range of clinical situations.
Other product segments include:
- Orbital Atherectomy Devices
- Photo-Ablative (Laser) Atherectomy Devices
- Rotational Atherectomy Devices
- Support Devices
By Application
Peripheral Vascular — Largest Application Segment
Peripheral vascular applications dominate, driven by the high prevalence of PAD and the critical need to restore blood flow in leg arteries. The minimally invasive character of atherectomy allows for short recovery periods and reduced complication risks compared to conventional surgery, driving adoption in this segment. Cardiovascular and neurovascular applications represent important and growing secondary segments.
By End User
Hospitals — Largest End-User Segment
Hospitals represent the dominant end-user segment due to the complexity of atherectomy procedures, which require advanced infrastructure and highly trained vascular specialists. Growth in this segment is further supported by increasing vascular surgery volumes, hospital investments in advanced technologies, and comprehensive post-operative care capabilities. Ambulatory Surgery Centers and Research Laboratories Academic Institutes represent additional end-user categories.
Regional Atherectomy Devices Market Share Analysis
North America – Largest Market
United States Canada; high cardiovascular disease prevalence, developed healthcare system, favorable reimbursement, strong RD investment, and presence of major market players
Europe
Germany, France, UK, Italy, Spain, Russia; mature healthcare systems, growing demand for minimally invasive vascular interventions, supportive digital health policies
Asia Pacific
China, Japan, India, South Korea, Australia, Indonesia; fast-expanding healthcare infrastructure, rising medical tourism, growing PAD awareness and treatment adoption
Latin America
Brazil, Mexico; Brazil is the largest LatAm healthcare market, improving reimbursement, and growing demand for advanced vascular interventions
Middle East Africa
UAE, Saudi Arabia, South Africa; healthcare modernization programs, rising chronic disease burden, and growing investment in interventional cardiology
Connect for Detailed Segmentation Analysis – Speak to an Analyst: https://www.imarcgroup.com/request?type=reportid=2766flag=C
Leading Players in the Atherectomy Devices Industry
The global atherectomy devices market features a mix of diversified medical device conglomerates and specialized interventional cardiology players. Key companies covered in the IMARC Group report include:
- Abbott Laboratories
- Avinger
- B. Braun Melsungen AG
- Biomerics
- Biotronik
- Boston Scientific Corporation
- C.R. Bard (Becton, Dickinson and Company)
- Cardinal Health
- Koninklijke Philips N.V.
- Medtronic
- Minnetronix Inc.
- Straub Medical AG (Becton, Dickinson and Company)
- Terumo Corporation
These players are deploying a range of competitive strategies to grow market share: significant RD investment to improve device efficacy and safety, strategic alliances to enhance knowledge sharing and distribution networks, and mergers and acquisitions to expand product portfolios and geographic reach. Regulatory approvals are a critical lever, with companies investing heavily to meet stringent safety and efficacy standards across multiple markets.
About Us
IMARC Group is a leading global market research company providing data-driven insights and expert consulting services to businesses seeking to achieve their strategic objectives. With a multi-disciplinary team of industry experts, IMARC delivers thorough, reliable market intelligence across sectors including Healthcare, Technology, Chemicals, Energy, Food Beverages, and more.
Contact Us
IMARC Group
United States: +1-201-971-6302
India: +91-120-433-0800
United Kingdom: +44-753-714-6104
